Hormone replacement therapy versus the combined oral contraceptive pill in premature ovarian failure: A randomized controlled trial of the effects on bone mineral density

Journal of Clinical Endocrinology and Metabolism

Volumn 101, Issue 9, 2016, Pages 3497-3505

  Cartwright, Beth ^a   Robinson, Jillian ^a   Seed, Paul T ^b   Fogelman, Ignac ^a   Rymer, Janice ^a  

^a GUY S HOSPITAL   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL VALERATE PLUS NORGESTREL; ETHINYLESTRADIOL PLUS LEVONORGESTREL; ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; BONE DENSITY; BONE TURNOVER; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; ENGLAND; FEMALE; FEMORAL NECK; HIP; HORMONE SUBSTITUTION; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; PREMATURE OVARIAN FAILURE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TEACHING HOSPITAL; ADOLESCENT; CASE CONTROL STUDY; COMPARATIVE STUDY; DRUG EFFECTS; FOLLOW UP; PRIMARY OVARIAN INSUFFICIENCY; PROGNOSIS; YOUNG ADULT;

ADOLESCENT; ADULT; BONE DENSITY; CASE-CONTROL STUDIES; CONTRACEPTIVES, ORAL, COMBINED; FEMALE; FOLLOW-UP STUDIES; HORMONE REPLACEMENT THERAPY; HUMANS; PRIMARY OVARIAN INSUFFICIENCY; PROGNOSIS; YOUNG ADULT;

EID: 84988959506     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2015-4063     Document Type: Article

References (30)

1. Pitkin J, Rees MC, Gray S, et al. Management of premature menopause. Menopause Int. 2007;13(1):44-45
2. Coulam CB, Adamson SC, Annegers JF. Incidence of premature ovarian failure. Obstet Gynecol. 1986;67(4):604-606
3. Popat VB, Calis KA, Vanderhoof VH, et al. Bone mineral density in estrogen-deficient young women. J Clin Endocrinol Metab. 2009; 94(7):2277-2283
4. Uygur D, Sengül O, Bayar D, Erdinç S, Batiolu S, Mollamahmutoglu L. Bone loss in young women with premature ovarian failure. Arch Gynecol Obstet. 2005;273(1):17-19
5. Jones KP, Ravnikar VA, Tulchinsky D, Schiff I. Comparison of bone density in amenorrheic women due to athletics, weight loss, and premature menopause. Obstet Gynecol. 1985;66(1):5-8
6. van Der Voort DJ, van Der Weijer PH, Barentsen R. Early menopause: increased fracture risk at older age. Osteoporos Int. 2003; 14(6):525-530
7. Svejme O, Ahlborg HG, Nilsson JÅ, KarlssonMK.Early menopause and risk of osteoporosis, fracture and mortality: a 34-year prospective observational study in 390 women. BJOG. 2012;119(7):810-816
8. Singer D, Mann E, Hunter MS, Pitkin J, Panay N. The silent grief: psychosocial aspects of premature ovarian failure. Climacteric. 2011;14(4):428-437
9. Kalu E, Panay N. Spontaneous premature ovarian failure: management challenges. Gynecol Endocrinol. 2008;24(5):273-279
10. Nelson LM, Covington SN, Rebar RW. An update: spontaneous premature ovarian failure is not an early menopause. Fertil Steril. 2005;83(5):1327-1332
11. Faculty of Sexual and Reproductive Healthcare Clinical Guidance: Combined Hormonal Contraception. https://www.guideline.gov/ summaries/summary/36071. Accessed on July 29, 2016
12. Sarri G, Davies M, Lumsden M on behalf of the Guideline Development Group. Diagnosis and management of menopause: summary of NICE guidance. 2015;351:h5746
13. Lindberg UB, Crona N, Stigendal L, Teger-Nilsson AC, Silfverstolpe G.Acomparison between effects of estradiol valerate and low dose ethinyl estradiol on haemostasis parameters. Thromb Haemost. 1989;61(1):65-69
14. Crofton PM, Evans N, Bath LE, et al. Physiological versus standard sex steroid replacement in young women with premature ovarian failure: effects on bone mass acquisition and turnover. Clin Endocrinol. 2010;73(6):707-714
15. Hanton L, Axelrod L, Bakalov V, Bondy CA. The importance of estrogen replacement in young women with Turner syndrome. J Womens Health (Larchmt). 2003;12(10):971-977
16. Cartwright B, Holloway D, Grace J, Robinson J, Rymer J. A service evaluation of women attending the menopause/premature ovarian failure clinic of a tertiary referral centre. J Obstet Gynaecol. 2012; 32(4):357-361
17. Cartwright B, Robinson J,RymerJ. Treatment of premature ovarian failure trial: description of an ongoing clinical trial. Menopause Int. 2010;16(1):18-22
18. Patel R, Blake GM, Rymer J, Fogelman I. Long-term precision of DXA scanning assessed over seven years in forty postmenopausal women. Osteoporos Int. 2000;11(1):68-75
19. Vickers AJ, Altman DG. Statistics notes: analysing controlled trials with baseline and follow up measurements. BMJ. 2001;323(7321): 1123-1124
20. White IR, Horton NJ, Carpenter J, Pocock SJ. Strategy for intention to treat analysis in randomised trials with missing outcome data. BMJ. 2011;342:d40
21. Schulz KF, Altman DG, Moher D, CONSORT Group. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomized trials. Open Med. 2010;4(1):e60-e68
22. Vujovic S, Brincat M, Erel T, et al. EMAS position statement: managing women with premature ovarian failure. Maturitas. 2010; 67(1):91-93
23. Ruggiero RJ, Likis FE. Estrogen: physiology, pharmacology, and formulations for replacement therapy. J MidwiferyWomensHealth. 2002;47(3):130-138
24. Herrmann M, Seibel MJ. The effects of hormonal contraceptives on bone turnover markers and bone health. Clin Endocrinol (Oxf). 2010;72(5):571-583
25. Vanin CM, MacLusky NJ, Grynpas MD, Casper RF. The effect of three hormone replacement regimens on bone density in the aged ovariectomized rat. Fertil Steril. 1995;63(3):643-651
26. Lindsay R, Gallagher JC, Kleerekoper M, Pickar JH. Effect of lower doses of conjugated equine estrogens with and without medroxyprogesterone acetate on bone in early postmenopausal women. JAMA. 2002;287(20):2668-2676
27. Tella SH, Gallagher JC. Prevention and treatment of postmenopausal osteoporosis. J Steroid Biochem Mol Biol. 2014;142:155-170
28. Blake GM, Fogelman I. The role of DXA bone density scans in the diagnosis and treatment of osteoporosis. Postgrad Med J. 2007; 83(982):509-517
29. Guttmann H, Weiner Z, Nikolski E, et al. Choosing an oestrogen replacement therapy in young adult women with Turner syndrome. Clin Endocrinol. 2001;54(2):159-164
30. Stone KL, Seeley DG, Lui LY, et al. BMD at multiple sites and risk of fracture of multiple types: long-term results from the Study of Osteoporotic Fractures. J Bone Miner Res. 2003;18(11):1947-1954